Weinstock, R. S., Guerci, B., Umpierrez, G., Nauck, M. A., Skrivanek, Z., & Milicevic, Z. (2015). Safety and efficacy of once‐weekly dulaglutide versus sitagliptin after 2 years in metformin‐treated patients with type 2 diabetes (AWARD‐5): A randomized, phase III study. Diabetes Obes Metab.
Citação norma ChicagoWeinstock, R. S., B. Guerci, G. Umpierrez, M. A. Nauck, Z. Skrivanek, and Z. Milicevic. "Safety and Efficacy of Once‐weekly Dulaglutide Versus Sitagliptin After 2 years in Metformin‐treated Patients With Type 2 Diabetes (AWARD‐5): A Randomized, Phase III Study." Diabetes Obes Metab 2015.
Citação norma MLAWeinstock, R. S., et al. "Safety and Efficacy of Once‐weekly Dulaglutide Versus Sitagliptin After 2 years in Metformin‐treated Patients With Type 2 Diabetes (AWARD‐5): A Randomized, Phase III Study." Diabetes Obes Metab 2015.